INmune Bio Inc (INMB)
5.21
-0.12
(-2.25%)
USD |
NASDAQ |
Sep 20, 16:00
5.18
-0.03
(-0.58%)
After-Hours: 20:00
INmune Bio Market Cap: 103.07M for Sept. 20, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
September 19, 2024 | 105.44M |
September 18, 2024 | 102.67M |
September 17, 2024 | 109.79M |
September 16, 2024 | 106.53M |
September 13, 2024 | 108.01M |
September 12, 2024 | 126.41M |
September 11, 2024 | 123.24M |
September 10, 2024 | 118.69M |
September 09, 2024 | 123.05M |
September 06, 2024 | 116.32M |
September 05, 2024 | 118.69M |
September 04, 2024 | 121.66M |
September 03, 2024 | 121.66M |
August 30, 2024 | 130.96M |
August 29, 2024 | 135.71M |
August 28, 2024 | 135.11M |
August 27, 2024 | 139.66M |
August 26, 2024 | 139.47M |
August 23, 2024 | 137.49M |
August 22, 2024 | 127.60M |
August 21, 2024 | 135.51M |
August 20, 2024 | 132.34M |
August 19, 2024 | 138.28M |
August 16, 2024 | 141.05M |
August 15, 2024 | 135.91M |
Date | Value |
---|---|
August 14, 2024 | 133.14M |
August 13, 2024 | 138.08M |
August 12, 2024 | 140.65M |
August 09, 2024 | 145.60M |
August 08, 2024 | 150.15M |
August 07, 2024 | 139.47M |
August 06, 2024 | 141.84M |
August 05, 2024 | 151.14M |
August 02, 2024 | 161.62M |
August 01, 2024 | 156.48M |
July 31, 2024 | 169.93M |
July 30, 2024 | 163.40M |
July 29, 2024 | 165.18M |
July 26, 2024 | 169.73M |
July 25, 2024 | 167.56M |
July 24, 2024 | 163.40M |
July 23, 2024 | 167.36M |
July 22, 2024 | 168.94M |
July 19, 2024 | 159.84M |
July 18, 2024 | 168.74M |
July 17, 2024 | 179.62M |
July 16, 2024 | 195.05M |
July 15, 2024 | 188.53M |
July 12, 2024 | 182.79M |
July 11, 2024 | 178.83M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
23.75M
Minimum
Mar 18 2020
496.89M
Maximum
Sep 07 2021
158.82M
Average
148.87M
Median
Market Cap Benchmarks
NovaBay Pharmaceuticals Inc | 3.518M |
Palatin Technologies Inc | 24.21M |
iBio Inc | 16.47M |
Theriva Biologics Inc | 3.910M |
Oragenics Inc | 2.638M |
Market Cap Related Metrics
PS Ratio | 729.44 |
PEG Ratio | -0.0940 |
Price to Book Value | 2.780 |
Price | 5.21 |
Earnings Yield | -39.54% |
PEGY Ratio | -0.0940 |